Industry News
02 Jun
Global Sunscreen Regulations: Key Requirements Across Major Markets
As consumer awareness of sun protection continues to grow, sunscreen products have become a critical segment of the global skincare market. However, regulatory requirements for sunscreen products vary significantly across regions, creating challenges for manufacturers seeking international expansion. Unlike many cosmetic products, sunscreens often fall into unique regulatory categories because they are intended to protect […]
02 Jun
OECD Report Highlights the Growing Impact of State Support on Global Industrial Competition
A recent OECD analysis has sparked significant discussion across global business and policy circles by concluding that nearly 60% of the global market share gains achieved by Chinese firms over the past two decades can be linked to government subsidies and state-backed support mechanisms. The findings highlight a broader debate about industrial policy, global […]
01 Jun
Samsung Epis Holdings Establishes New R&D Center in China: Strengthening Innovation in a Competitive Biopharmaceutical Landscape
The establishment of a new R&D center in China by Samsung Epis Holdings reflects a broader strategic trend reshaping the global biopharmaceutical industry. As competition intensifies across biosimilars, biologics, and advanced therapeutics, leading healthcare companies are increasingly expanding their research footprints into key innovation hubs to accelerate product development, access specialized talent, and strengthen regional […]
29 May
FDA Registration Updates Signal a New Era of Compliance and Competitive Differentiation in the Cosmetics Industry
The U.S. Food and Drug Administration’s recent updates to its web portal and informational resources designed to help cosmetic facilities prepare for biennial registration renewal may appear administrative on the surface. However, the development reflects a much larger transformation taking place across the global beauty and personal care industry. As regulatory requirements become more structured […]
28 May
Asia Drug Development Beyond China: Strategic Intelligence Report 2026
Pharma R&D and Deal Trends in South Korea and Japan Asia’s pharmaceutical innovation landscape is undergoing a major transformation. While China has dominated discussions around Asian biotech growth over the past decade, increasing attention is now shifting toward other high-value innovation hubs across the region — particularly South Korea and Japan. These markets are emerging […]
27 May
How L’Oréal’s Open Innovation Strategy Is Reshaping the Future of Beauty Tech
The beauty industry is undergoing one of the most significant transformations in its history, driven by rapid advancements in artificial intelligence, biotechnology, personalization, digital commerce, and connected consumer experiences. In this evolving landscape, innovation is no longer confined to internal R&D laboratories. Instead, global beauty leaders are increasingly adopting open innovation models that combine internal […]
26 May
Hengrui Pharma and Bristol Myers Squibb Partnership Reflects the Globalization of Next-Generation Biopharma Innovation
The collaboration between Hengrui Pharma and Bristol Myers Squibb highlights a growing transformation in the global pharmaceutical industry where innovation, commercialization, and drug development are becoming increasingly international and partnership-driven. As competition intensifies across oncology, hematology, and immunology markets, pharmaceutical companies are accelerating strategic alliances to strengthen R&D pipelines, expand global reach, and reduce development […]
25 May
Coty’s Marc Jacobs Beauty Relaunch Reflects the New Competitive Landscape in Prestige Beauty
The relaunch of Marc Jacobs Beauty through a global Sephora rollout marks one of the most significant prestige beauty comebacks in recent years. More than a nostalgic brand revival, the move highlights how global beauty companies are reshaping growth strategies around premiumization, retail partnerships, experiential branding, and emotionally driven consumer engagement. Coty’s decision to revive […]
22 May
AI-Powered Gene Mapping Signals a New Era of Predictive Biology and Precision Medicine
The development of advanced AI models capable of mapping how genes interact within human cells marks a major breakthrough in modern biotechnology and computational biology. By analyzing the complex relationships between genes, proteins, and cellular systems, researchers are moving closer to understanding the biological networks that drive human health, disease progression, and therapeutic response. This […]
21 May
Next-Generation RNA Targeting Is Redefining the Future of Precision Medicine
The emergence of advanced RNA-targeting CRISPR technologies represents one of the most significant shifts occurring in modern biotechnology and precision medicine. While traditional CRISPR systems transformed the life sciences industry through DNA editing capabilities, the next wave of innovation is increasingly focused on programmable RNA-targeting platforms with broader diagnostic, therapeutic, and antiviral applications. This transition […]